Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (2020)

First Author: Folegatti P

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(20)31604-4

Publication URI: http://dx.doi.org/10.1016/s0140-6736(20)31604-4

Type: Journal Article/Review

Parent Publication: The Lancet

Issue: 10249